FIELD: chemistry.
SUBSTANCE: invention relates to novel anti-tumour compounds which are kahalalide F derivatives, pharmaceutical compositions containing said derivatives and their use in preparing an anti-tumour medicinal agent.
EFFECT: obtaining novel anti-tumour compounds.
4 cl, 9 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| KAHALALIDE COMPOUNDS | 2001 |
|
RU2280039C2 |
| NOVEL ANTITUMOR COMPOUNDS | 2003 |
|
RU2356908C2 |
| INHIBITORS OF VIIA FACTOR | 1999 |
|
RU2223967C2 |
| PEPTIDE ANALOGUES GH-RH WITH OPPOSING ACTION, WAY OF DEPRESSION OF GH LEVEL, WAY OF DEPRESSION OF IGF-INIGF-II LEVEL, APPLICATION FOR INHIBITION OF GROWTH OF CANCER CELLS, PHARMACOLOGICALLY ACCEPTABLE COMPOSITION (VARIANTS) | 2004 |
|
RU2335506C2 |
| EXENATIDE ANALOGUE | 2020 |
|
RU2823623C1 |
| ANALOGUES OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1), CONTAINING AMINO ACID SUBSTITUTION IN POSITION 59 | 2010 |
|
RU2511577C2 |
| ANTAGONISTIC ANALOGUES OF GROWTH HORMONE RELEASING-HORMONE (GH-RH) INHIBITING INSULIN-LIKE GROWTH FACTORS (IGF-I AND -II) | 1999 |
|
RU2235099C2 |
| RGD-CONTAINING PEPTIDOMIMETICS AND THEIR APPLICATION | 2009 |
|
RU2519736C2 |
| CYCLIC PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2096415C1 |
| SULFOMALEIMIDE-BASED LINKERS AND CORRESPONDING CONJUGATES | 2019 |
|
RU2815199C2 |
